Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas

被引:0
|
作者
Takahiro Yamauchi
Makoto Ohno
Yuko Matsushita
Masamichi Takahashi
Yasuji Miyakita
Yosuke Kitagawa
Erika Kondo
Natsuko Tsushita
Kaishi Satomi
Akihiko Yoshida
Koichi Ichimura
Yoshitaka Narita
机构
[1] National Cancer Center Hospital,Department of Neurosurgery and Neuro
[2] National Cancer Center Hospital,Oncology
[3] National Cancer Center Research Institute,Department of Pathology and Clinical Laboratories
[4] University of Fukui,Division of Brain Tumor Translational Research
来源
Brain Tumor Pathology | 2018年 / 35卷
关键词
Lower-grade glioma; Radiological features; Isocitrate dehydrogenase mutations; 1p/19q codeletion;
D O I
暂无
中图分类号
学科分类号
摘要
The radiological features of lower-grade gliomas (LGGs) classified according to isocitrate dehydrogenase (IDH) mutations and codeletion of chromosomal arms 1p and 19q (1p/19q codeletion) remain unclear. We aimed to systematically characterize the radiological features of molecularly classified LGGs using IDH and 1p/19q codeletion statuses. One hundred and one LGGs were re-classified into 36 tumors with IDH mutations (IDH-Mut), 35 tumors with IDH-Mut and 1p/19q codeletion (IDH-Mut/Codel), and 30 tumors with wildtype IDH (IDH-Wt). Calcification, heterogeneous signal intensity in T2-weighted images, and cortical invasion were significantly more frequent in IDH-Mut/Codel than in IDH-Mut and IDH-Wt tumors (calcification: 48.6 vs 5.6 and 6.7%, heterogeneity: 94.3 vs 33.3 and 50%, and cortical invasion: 94.3 vs 55.6 and 40.0%, respectively). A frontal location was significantly more frequent for IDH-Mut and IDH-Mut/Codel than for IDH-Wt tumors (52.8 and 71.4 vs 12.1%, respectively), and dense contrast-enhancement was significantly more frequent in IDH-Wt than in IDH-Mut and IDH-Mut/Codel tumors (50.0 vs 2.8 and 2.9%, respectively). In conclusion, IDH-Mut/Codel tumors were characterized by calcification, frontal location, heterogeneous signal intensity, and cortical invasion; IDH-Mut tumors differed from IDH-Wt tumors according to predominant frontal lobe location and less frequent dense enhancement patterns.
引用
收藏
页码:148 / 158
页数:10
相关论文
共 50 条
  • [1] Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas
    Yamauchi, Takahiro
    Ohno, Makoto
    Matsushita, Yuko
    Takahashi, Masamichi
    Miyakita, Yasuji
    Kitagawa, Yosuke
    Kondo, Erika
    Tsushita, Natsuko
    Satomi, Kaishi
    Yoshida, Akihiko
    Ichimura, Koichi
    Narita, Yoshitaka
    BRAIN TUMOR PATHOLOGY, 2018, 35 (03) : 148 - 158
  • [2] MRI-based radiogenomics analysis of 1p/19q codeletion in grade II and III gliomas
    Takahashi, W.
    Nakamoto, T.
    Akihiro, H.
    Satoshi, T.
    Shota, T.
    Aoki, S.
    Kiritoshi, T.
    Ogita, M.
    Yamashita, H.
    Nakagawa, K.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1057 - S1058
  • [3] RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion
    Sean Chun-Chang Chen
    Chung-Ming Lo
    Shih-Hua Wang
    Emily Chia-Yu Su
    BMC Bioinformatics, 20
  • [4] RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion
    Chen, Sean Chun-Chang
    Lo, Chung-Ming
    Wang, Shih-Hua
    Su, Emily Chia-Yu
    BMC BIOINFORMATICS, 2019, 20 (01)
  • [5] Relevance of 1p and 19q for patients with who grade II/III gliomas
    Iwamoto, F. M.
    Nicolardi, L.
    Demopoulos, A.
    Barbashina, V.
    Ladanyi, M.
    DeAngelis, L. M.
    Hormigo, A.
    NEURO-ONCOLOGY, 2006, 8 (04) : 458 - 458
  • [6] Gliomas With 1p/19q Codeletion: a.k.a. Oligodendroglioma
    Cairncross, Gregory
    Jenkins, Robert
    CANCER JOURNAL, 2008, 14 (06): : 352 - 357
  • [7] IS ATRX IMMUNOCHEMISTRY USEFUL AS A SUBSTITUTE FOR ANALYSIS OF 1p/19q CODELETION IN GRADES II, III GLIOMAS?
    Yamamichi, Akane
    Ohka, Fumiharu
    Aoki, Kosuke
    Suzuki, Hiromichi
    Hirano, Masaki
    Motomura, Kazuya
    Wakabayashi, Toshihiko
    Kato, Yukinari
    Natsume, Atsushi
    NEURO-ONCOLOGY, 2017, 19 : 180 - 180
  • [8] MRI and CT Identify Isocitrate Dehydrogenase (IDH)-Mutant Lower-Grade Gliomas Misclassified to 1p/19q Codeletion Status with Fluorescence in Situ Hybridization
    Patel, Sohil H.
    Batchala, Prem P.
    Mrachek, E. Kelly S.
    Lopes, Maria-Beatliz S.
    Schiff, David
    Fadul, Camilo E.
    Patrie, James T.
    Jain, Rajan
    Druzgal, T. Jason
    Williams, Eli S.
    RADIOLOGY, 2020, 294 (01) : 160 - 167
  • [9] Alpha Internexin: A Surrogate Marker for 1p/19q Codeletion and Prognostic Marker in Anaplastic (WHO grade III) Gliomas
    Rajmohan, K. S.
    Sugur, Harsha S.
    Shwetha, S. D.
    Pandey, Paritosh
    Arivazhagan, Arimappamagan
    Santosh, Vani
    NEUROLOGY INDIA, 2020, 68 (04) : 832 - 837
  • [10] IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas
    Appay, Romain
    Tabouret, Emeline
    Macagno, Nicolas
    Touat, Mehdi
    Carpentier, Catherine
    Colin, Carole
    Ducray, Francois
    Idbaih, Ahmed
    Mokhtari, Karima
    Uro-Coste, Emmanuelle
    Dehais, Caroline
    Figarella-Branger, Dominique
    NEURO-ONCOLOGY, 2018, 20 (05) : 716 - 718